Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63,129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PALB2 mutations in familial breast and pancreatic cancer.
Hofstatter EW, Domchek SM, Miron A, Garber J, Wang M, Componeschi K, Boghossian L, Miron PL, Nathanson KL, Tung N. Hofstatter EW, et al. Among authors: wang m. Fam Cancer. 2011 Jun;10(2):225-31. doi: 10.1007/s10689-011-9426-1. Fam Cancer. 2011. PMID: 21365267 Free PMC article.
A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial.
Moulder S, Li H, Wang M, Gradishar WJ, Perez EA, Sparano JA, Pins M, Yang X, Sledge GW. Moulder S, et al. Among authors: wang m. Breast Cancer Res Treat. 2010 Feb;119(3):663-71. doi: 10.1007/s10549-009-0658-9. Breast Cancer Res Treat. 2010. PMID: 20012354 Free PMC article. Clinical Trial.
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer.
Schneider BP, Zhao F, Wang M, Stearns V, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE, Sparano JA. Schneider BP, et al. Among authors: wang m. J Clin Oncol. 2012 Sep 1;30(25):3051-7. doi: 10.1200/JCO.2011.39.8446. Epub 2012 Jul 30. J Clin Oncol. 2012. PMID: 22851566 Free PMC article. Clinical Trial.
Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group trial E3198.
Wolff AC, Wang M, Li H, Pins MR, Pretorius FJ, Rowland KM, Sparano JA, Davidson NE. Wolff AC, et al. Among authors: wang m. Breast Cancer Res Treat. 2010 May;121(1):111-20. doi: 10.1007/s10549-010-0838-7. Epub 2010 Mar 24. Breast Cancer Res Treat. 2010. PMID: 20333545 Free PMC article. Clinical Trial.
A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103).
Li T, Guo M, Gradishar WJ, Sparano JA, Perez EA, Wang M, Sledge GW. Li T, et al. Among authors: wang m. Breast Cancer Res Treat. 2012 Jul;134(1):345-52. doi: 10.1007/s10549-012-2071-z. Epub 2012 May 1. Breast Cancer Res Treat. 2012. PMID: 22547107 Free PMC article. Clinical Trial.
Weekly paclitaxel in the adjuvant treatment of breast cancer.
Sparano JA, Wang M, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE. Sparano JA, et al. Among authors: wang m. N Engl J Med. 2008 Apr 17;358(16):1663-71. doi: 10.1056/NEJMoa0707056. N Engl J Med. 2008. PMID: 18420499 Free PMC article. Clinical Trial.
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, Miller KD; ECOG 2100. Schneider BP, et al. Among authors: wang m. J Clin Oncol. 2008 Oct 1;26(28):4672-8. doi: 10.1200/JCO.2008.16.1612. J Clin Oncol. 2008. PMID: 18824714 Free PMC article. Clinical Trial.
63,129 results
You have reached the last available page of results. Please see the User Guide for more information.